Kiora Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule,…

Biotechnology
US, Salt Lake City [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Kiora Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Kiora Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Kiora Pharmaceuticals, Inc..

End of KPRX's Analysis
CIK: 1372514 CUSIP: 49721T101 ISIN: US49721T3095 LEI: - UEI: -
Secondary Listings
KPRX has no secondary listings inside our databases.